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Abstract: A wide range of frogs produce skin poisons composed of bioactive peptides for defence
against pathogens, parasites and predators. While several frog families have been thoroughly screened
for skin-secreted peptides, others, like the Microhylidae, have remained mostly unexplored. Previous
studies of microhylids found no evidence of peptide secretion, suggesting that this defence adaptation
was evolutionarily lost. We conducted transcriptome analyses of the skins of Phrynomantis bifasciatus
and Phrynomantis microps, two African microhylid species long suspected to be poisonous. Our
analyses reveal 17 evolutionary related transcripts that diversified from to those of cytolytic peptides
found in other frog families. The 19 peptides predicted to be processed from these transcripts, named
phrynomantins, show a striking structural diversity that is distinct from any previously identified frog
skin peptide. Functional analyses of five phrynomantins confirm the loss of a cytolytic function and
the absence of insecticidal or proinflammatory activity, suggesting that they represent an evolutionary
transition to a new, yet unknown function. Our study shows that peptides have been retained in the
defence poison of at least one microhylid lineage and encourages research on similarly understudied
taxa to further elucidate the diversity and evolution of skin defence molecules.
Keywords: amphibians; frogs; Microhylidae; poison; peptides; evolution
1. Introduction
The amphibian skin is a delicate but sophisticated organ that is directly exposed to the challenges
of the animal’s environment. To ward off harmful microorganisms, or to prevent becoming a
predator’s next meal, a wide range of frogs (Anura) secrete a mixture of antimicrobial peptides
and toxins from poison glands in their skin [1–3]. Over the past decades, these bioactive peptides
have been predominantly studied from a pharmacological perspective, focussing on their potential
medical application in wound healing [4,5], regulating glucose metabolism [6,7] and acting as
broad-spectrum antibiotics [8,9]. Although the presence of skin peptides has been described in 13
anuran families [1,2,10], only five lineages appear to have received the great majority of scientific
attention. Besides the genera Xenopus (Pipidae) and Bombina (Bombinatoridae), a limited number of
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genera in the families Phyllomedusidae (Agalychnis and Phyllomedusa), Pelodryadidae (Litoria) and
Ranidae (Rana, Lithobates and Odorrana) have been particularly thoroughly explored for the presence
of therapeutically promising peptides [11–13]. These peptides often display different bioactivities
and range from antimicrobial or antioxidant agents, to hormone analogues that can cause sickness,
hypotension or inflammation [1,2]. Despite their structural and functional differences, most of these skin
peptides are posttranslationally cleaved from evolutionary related (homologous) precursor proteins
that descended from a single ancestral gene in an early neobatrachian (advanced) frog an estimated 150
million years ago [11,12,14,15]. Related precursor proteins have been described in species of the frog
families Leptodactylidae, Hyperoliidae, Dicroglossidae and Rhacophoridae, indicating that the same
molecular defence system has been evolutionary preserved in several less explored neobatrachian
families [2,15]. These precursor proteins have been classified in the ‘Frog Skin Active Peptide’ (FSAP)
superfamily in the Uniprot database [16,17] and comprises a multitude of different peptide families
defined on the basis of their taxonomic occurrence and/or sequence similarity (including brevinins,
temporins, esculentins, caerins and dermaseptins and many others). FSAP precursor proteins are
typically between 60 and 200 amino acids long and contain an evolutionary conserved N-terminal signal
peptide and one or several acidic spacer regions (similar to vertebrate prepro-hormone precursors)
that are proteolytically cleaved from the C-terminal bioactive peptide [1,12,14]. Although the past
two decades have seen a drastic increase in our knowledge of the FSAP superfamily [1,2,11,13], the
focus on a select number of frog taxa has left the skin secretions of a large diversity of neobatrachian
frogs unexplored.
One such poorly explored taxon is the family Microhylidae (narrow-mouthed frogs). Microhylidae
represent one of the largest and most ecologically diverse frog families, with well over 600 recognised
species in 13 subfamilies distributed across the Americas, Asia, Africa, Madagascar and the
Australo-Papuan region [18,19]. Despite this diversity, the study of skin secretion has been limited
to a handful of species [1,20]. A toxinological analysis of the South American species Dermatonotus
muelleri (Gastrophryninae) revealed high concentrations of the amino acid tryptophan [21], while for
the Madagasacan Dyscophus guineti (Dyscophinae) and the Asian Kaloula pulchra (Microhylinae), only
serine protease inhibitor proteins were identified [22,23]. None of these species were found to secrete
peptides. However, peptides of the FSAP superfamily may have been preserved in the African genus
Phrynomantis (Phrynomerinae). Species of this genus are conspicuously coloured and at least two of
them, Phrynomantis microps and Phrynomantis bifasciatus, are known to be toxic [24,25]. In addition,
two peptides have been described from the skin secretion of P. microps [20]. During dry periods,
this species is known to take shelter in the nests of Paltothyreus tarsatus, an aggressive ant species
that otherwise attacks any nest intruder [20,26]. The two identified peptides were shown to delay
the aggressive behaviour of the ants, indicating that these compounds may be involved in a form of
chemical camouflage or appeasement [20].
We conducted a transcriptome analysis to investigate the expression of peptide-encoding genes in
the skins of the species P. bifasciatus and P. microps. Although the genetic basis of the two previously
identified P. microps peptides remains undisclosed, our study shows that FSAP-related peptides have
been retained in this microhylid lineage. Because of their highly derived sequences, we describe the
identified peptides as a new family called phrynomantins.
2. Results
2.1. Skin Transcriptomes Elucidate the Diversity of Secretory Proteins in Phrynomantis
To obtain an overview of the genes expressed in the skin of the two Phrynomantis species, we
extracted total RNA from dorsal skin. RNA-seq analysis of these samples (see Methods) yielded totals
of 51.76 million and 30.58 million high-quality reads for P. bifasciatus and P microps, respectively. De
novo transcript assembly using Trinity [27] and subsequent clustering of very similar contigs using
CD-hit [28] resulted in 250,508 (P. bifasciatus) and 188,220 (P. microps) nonredundant transcript contigs
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for both species respectively. Subsequent mapping of reads against these transcript contigs reveal a
similarly skewed expression profile for both libraries, in which only 759 transcript contigs (P. bifasciatus)
and 780 transcript contigs (P. microps) have estimated expression levels above 100 transcripts per million
(TPM). Screening of both transcript libraries using the Basic Local Alignment Search Tool (BLAST) of
the Genbank database of the National Center for Biotechnology Information (NCBI) indicates that many
of their highest expressed transcripts encode intracellular housekeeping genes (like ribosomal proteins
and elongation factors) and extracellular structural protein genes (like keratins, tectorin-like proteins
and mucins). In addition, BLAST searches against the same database as well as an in-house database
of published amphibian secretory precursor proteins show that other highly expressed transcripts in
Phrynomantis encode members of multiple protein families that are frequently encountered in frog skin
secretions (Table 1). First, by far the highest expressed is the FSAP superfamily, accounting for ten
full-length transcripts totalling 13,437 TPM in P. bifasciatus and seven full-length transcripts adding
up to 12,637 TPM in P. microps. As the FSAP superfamily constitutes a major component of skin
secretions in other frog lineages, their finding in Phrynomantis is a first indication that peptide secretion
has been evolutionary preserved in at least one microhylid lineage. Second, our BLAST searches
demonstrate the expression of at least five antimicrobial peptide/protein families that are known
from a wide range of vertebrates (Table 1). While transcripts encoding beta-defensin, cathelicidin
and G-type lysozyme are expressed at low levels (all <10 TPM), bactericidal permeability-increasing
protein (BPI) and C-type lysozyme transcripts are highly expressed (>100 TPM). Third, a large number
of transcripts encode small proteins with cysteine motifs (domains) that characterise five different
families of serine protease inhibitors as defined in the Uniprot and PFAM databases [17,29]. These
include Kazal-type serine protease inhibitor domain (protein family PF00050), kunitz/bovine pancreatic
trypsin inhibitor (BPTI) domain (PF00014), serpin-type domain (PF00079), trypsin-inhibitor like (TIL)
cysteine rich domain (PF01826) and whey acidic protein-type (WAP) ‘four-disulphide core’ domain
(PF00095). The combined expression values of these transcripts indicate that serine protease inhibitors
are a major functional class of proteins in the skins of both Phrynomantis species (Table 1). Fourth,
BLAST searches did not reveal any transcripts that encode apparent hormone-derived toxins as found
in other amphibians, like bombesins, caeruleins or prokineticins. However, transcripts encoding the
hormones gastrin, glucagon, bradykinin, natriuretic peptide, neurotensin were recovered at very low
expression levels (<10 TPM). One exception is secretogranin, a common constituent of vertebrate
endocrine gland granules involved in granule biogenesis and acting as precursor protein of several
subsequently cleaved hormone peptides [30]. Finally, we did not identify any transcript encoding a
candidate precursor protein of either of the two previously described P. microps peptides [20]. Apart
from blastx searches, a text screen of the peptide sequences obtained by translating all open-reading
frames above 150 base pairs in our libraries did not reveal either one of the peptides’ sequences.
2.2. Phrynomantins: The First Microhylid Representatives of the FSAP Superfamily
The recovered FSAP transcripts encode precursor proteins between 44 and 110 amino-acids
long, including an N-terminal signal peptide, an acidic spacer that typifies proteins of the FSAP
superfamily and one or several lysine-arginine and arginine-arginine motifs corresponding to common
peptidase cleavage sites (Figure 1). Sequence alignments show that two types of precursor proteins
can be distinguished in both Phrynomantis species, mainly differing by variation in the signal peptide
sequences and length of their acidic spacers.
Based on putative cleavage sites, we predict the processing of at least ten different peptides from
these precursor proteins in P. bifasciatus and nine peptides in P. microps (Figure 1, Table 2). Four precursor
proteins seem to include two or three tandemly organised peptides, some of which are very similar or
even identical to each other (e.g., phrynomantin-1Bb and -1Ma/b/c). One peptide, phrynomantin-2Ma,
is processed from two different precursor proteins (phrynomantin-2Ma1 and -2Ma2). While the
majority of FSAP in other frog taxa is cationic, 13 of the 19 predicted phrynomantins have a negative
net charge (Table 2). In addition, most of them seem to lack the capacity to adopt an alpha-helical
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conformation, as predicted by the online prediction tool PsiPred [31]. Liquid chromatography-mass
spectrometry (LC-MS) analysis of P. microps skin secretion confirmed the presence of three of its nine
predicted peptides—phrynomantin-M1b, -M1d and -M4a (Figure 2).
Table 1. Protein families encoded by recovered transcripts in both Phrynomantis species, including
estimated transcript diversity (number of assembled transcript contigs) and estimated total expression
level (sum of transcripts per million (TPM) of contigs representing the same gene/protein family).









Frog Skin Active Peptide (FSAP)






48 992.4 38 479.6
Beta-defensin 1 1.7 1 3.5
Cathelicidin 6 5.1 5 4.8
C-type lysozyme 9 127.4 6 578.9
G-type lysozyme 12 5.6 2 5.0
Serine protease inhibitor families
Kazal-like 1 408.4 4 534.7
Kunitz/Bovine pancreatic trypsin
inhibitor (BPTI) 20 941.0 15 423.4
Serpin-type 60 773.2 60 2119.8
Trypsin inhibitor-like (TIL) 39 10,424.7 45 4252.5
Whey acidic protein (WAP) 26 506.0 20 825.2
Hormone/neuropeptide-like
peptide families
Angiotensin 1 1.9 0 0
Bradykinin (kininogen) 2 2.9 1 7.2
Gastrin 1 0.2 0 0
Glucagon 1 1.0 0 0
Natriuretic peptide 2 2.2 1 3.3
Neurotensin/Neuromedin N 1 0.7 0 0
Secretin 1 5.0 1 1.4
Secretogranin 11 35.6 8 70.0
Tachykinin 0 0 2 7.1
1 Calculated by summing the expression levels (in transcripts per million (TPM)) of all transcript contigs identified
as encoding members of the same protein family.
Molecules 2020, 25, 912 4 of 19 
 
Serine protease inhibitor 
families     
Kazal-like 1 408.4 4 534.7 
Kunitz/Bovine pancreatic trypsin 
inhibitor (BPTI) 
20 941.0 15 423.4 
Serpin-type 60 773.2 60 2119.8 
Trypsin inhibitor-like (TIL)  39 10424.7 45 4252.5 
Whey acidic protein (WAP)  26 506.0 20 825.2 
Hormone/neuropeptide-like 
peptide families 
Angiotensin 1 1.9 0 0 
Bradykinin (kininogen) 2 2.9 1 7.2 
Gastrin 1 0.2 0 0 
Glucagon 1 1.0 0 0 
Natriuretic peptide 2 2.2 1 3.3 
Neurotensin/ 
Neuromedin N 
1 0.7 0 0 
Secretin 1 5.0 1 1.4 
S cretogranin 11 35.6 8 70.0 
Tachykinin 0 0 2 7.1 
1 Calculated by summing the expression levels (in transcripts per million (TPM)) of all transcript 
contigs identified as encoding members of the same protein family. 
2.2. Phry omantins: the First Microhylid Representatives of the FSAP Superfamily 
The recovered FSAP transcripts encode precursor proteins between 44 and 110 amino-acids 
long, in lud g an N-terminal signal peptide, an acidic spacer that typifies proteins of the FSAP 
superfamily and one or several lysine-arginine and arginine-arginine motifs corresponding to 
common peptidase cl avage sites (Figure 1). Sequence alignments show that two types of precursor 
proteins can be distinguished in both Phrynomantis species, mainly differing by variation in the signal 
peptide sequences and length of their acidic spacers. 
 
Figure 1. Sequence alignment of the 17 phrynomantin precursor proteins encoded by Phrynomantis 
skin transcripts. Predicted N-terminal signal peptides are printed in lower case, putative cleavage 
sites are underlined, predicted functional peptides (19 in total) are bold-faced. Conserved residues 
(identical in ≥50% of aligned sequences) are shaded in grey. Numbers behind sequences represent 
expression estimates (in transcripts per million; TPM). 
Based on putative cleavage sites, we predict the processing of at least ten different peptides from 
these precursor proteins in P. bifasciatus and nine peptides in P. microps (Figure 1, Table 2). Four 
precursor proteins seem to include two or three tandemly organised peptides, some of which are 
very similar or even identical to each other (e.g., phrynomantin-1Bb and -1Ma/b/c). One peptide, 
phrynomantin-2Ma, is processed from two different precursor proteins (phrynomantin-2Ma1 and -
Figure 1. Sequence alignment of the 17 phrynomantin precursor proteins encoded by Phrynomantis
skin transcripts. Predicted N-terminal signal peptides are printed in lower c s , tative cleavage sites
are underlined, predicted funct onal peptides (19 n total) are bold-face . Conserved r sidues (identical
in ≥50% of aligned sequences) are shaded in grey. Numbers behind sequences represent expression
estimates (in transcripts per million; TPM).
Molecules 2020, 25, 912 5 of 18
Table 2. Physicochemical and structural properties of the predicted phrynomantins.
Peptide Sequence 1 Length MW (Da) 3 Net charge 4 GRAVY 5 Helicity (%) 6
phrynomantin-1Ba GLVTNLLSSVR 11 1158.4 1 0.84 72.7
phrynomantin-1Bb GLVPDLDLPVDL 12 1265.5 −3 0.79 0
phrynomantin-1Bc GIVNNLLSTVL 11 1142.4 0 1.40 81.8
phrynomantin-1Bd GPVFDYLSQVYPVR 14 1639.9 0 0.05 50
phrynomantin-1Be GLVKDILSLDVL 12 1284.5 −1 1.33 66.7
phrynomantin-1Bf GLVPDLDLPVDLPV 14 1461.7 −3 0.86 0
phrynomantin-1Ma GLVKNQDLPVDLAAVF 16 1699.0 −1 0.66 12.5
phrynomantin-1Mb GLVKNLNLPVDVPVDL 2 16 1705.0 −1 0.66 0
phrynomantin-1Mc GLVKDLNLPVDVPVDLPV 18 1902.2 −2 0.73 0
phrynomantin-1Md GLVKDLLSLDV2 11 1171.4 −1 1.05 63.6
phrynomantin-2Ba DYEAVSL 7 795.8 −2 0.10 0
phrynomantin-2Ma DYEPASL 7 793.8 −2 −0.73 0
phrynomantin-3Ba SEWPPVRGDNGEYDVEL 17 1962.0 −4 −1.19 0
phrynomantin-3Ma SEWPPVRGDAGEYDVEL 17 1919.0 −4 −0.88 0
phrynomantin-3Mb AEWRLL 6 786.9 0 0.08 0
phrynomantin-3Mc AEWRLLKNa 8 1028.2 2 −0.86 0
phrynomantin-4Ba NAASRLYTPYSPTK 14 1568.7 2 −0.95 0
phrynomantin-4Bb NARNFNSFDPFNTSD 15 1745.8 −1 −1.28 0
phrynomantin-4Ma NTENFFNPFNPFV2 13 1586.7 −1 −0.46 0
1 Residues predicted to be involved in helical structure are underlined; a, C-terminal amidation. 2 Presence in
secretion confirmed by LC-MS. 3 MW, Molecular weight. 4 at pH = 7.0. 5 GRAVY, Grand average of hydropathy. 6
As predicted using Psipred [31].
2.3. Phrynomantins Serve a yet Unknown Function
Five P. microps peptides were de novo synthesised and tested for various bioactivities. These
peptides included the three phrynomantins confirmed by LC-MS and were further selected to represent
the highest expressed transcripts and broadly cover the sequence diversity of phrynomantins. Even at a
high concentration (512 µM), none of these peptides showed cytolytic activity against the gram-negative
bacterial species Escherichia coli, the gram-positive species Staphylococcus aureus or against Caco-2
human epithelial cells (data not shown).
Braun et al. [26] mention a toxic effect of P. microps poison towards ants. To test whether newly
discovered peptides could function as general insecticidal toxins, we performed toxicity experiments
with the greater wax moth Galleria mellonella. Injection of P. microps skin secretion resulted in death
of the wax moth larvae within one minute, showing a potent insecticidal effect. However, when
individual peptides were injected, no reduced crawling activity was observed after either 10 min
(Figure 3A; X2 = 8.12, df = 8, p = 0.422) or 60 min (Figure 3B; X2 = 5,16, df = 8, p = 0.740). Similarly,
none of the peptides caused changes in larval body colouration or response to stimuli. Injecting the
five peptides together did not have any significant effect either, indicating the absence of a synergistic
activity between these peptides.
The skin secretion of P. microps has been described as causing an inflammatory response
in humans [32]. We therefore tested the effect of the five phrynomantins on the production of
proinflammatory cytokines by murine spleen and bone marrow cell cultures [33]. When treating these
cell cultures with the peptides at concentrations of 100 µM, no change in proinflammatory cytokine
secretion compared to a negative control was apparent (Figure 3C–F). On the contrary, treating immune
cells with bacterial LPS resulted in an expected increase in the secretion of TNF-α, IFN-γ, NO and IL-6
after 24 h, indicating that our experimental setup worked correctly.
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average (horizontal line). Overlapping symbols might appear as singl data points. Peptides are
labelled as phr (phrynomantin) with their respective peptide number (see Table 2), Bg = background
(no injection), Nc = negative control (injection of water), mix = mixture of all tested phrynomantins
(each at 1 mM), LPS = E. coli endotoxin/lipopolysaccharide.
2.4. Evolutionary Origin and Diversification of Phrynomantins
Phylogenetic reconstruction of FSAP superfamily evolution is a priori unrooted since it is impossible
to assign a reliable outgroup to the dataset (i.e., homologous sequences for which a basal divergence
with FSAP sequences is certain). However, by applying the maximum parsimony principle to gene
duplication and loss (i.e., minimising the number of duplication events), the tree can be rooted
such that it implies a single basal divergence between hyloid and ranoid sequences (Figure 4).
The resulting rooted tree is largely compatible with current hypotheses regarding the phylogenetic
relationships of major neobatrachian frog lineages [34–36]. Besides providing maximum support for the
ranoid-hyloid bipartition, high Bayesian posterior probabilities were obtained for clades combining—(1)
all dicroglossid sequences, (2) all dicroglossid + ranid sequences, (3) all Kassina sequences and (4)
all phrynomantins. In addition, phrynomantins were recovered as the sister lineage of the Kassina
clade, which is consistent with a closer relationship between Hyperoliidae (to which Kassina belongs)
and Microhylidae (to which Phrynomantis belongs) [35,36]. Within the phrynomantin clade, two
well-supported branches confirm our previous observation of the presence of two distinct precursor
types, separating phrynomantins-1 and -2 from phrynomantins-3 and -4 (compare Figures 1 and 4).
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3. Discussion
We used transcriptomic analyses to obtain a comprehensive overview of the diversity of
skin-secreted peptides and proteins in two species of Phrynomantis, a microhylid genus long suspected
to be poisonous. Our data reveal both similarities and differences with the skin secretions of other
frog taxa. A first similarity is the presence of serine protease inhibitors; the large diversity and
high expression of multiple transcripts indicate that these constitute an important skin component
in Phrynomantis species. The five families of serine protease inhibitors found in the skin of both
species (Table 1) have been found before in other taxa, although typically as one or few closely related
proteins [2,22,37–40]. Our results demonstrate that a frog’s skin repertoire of serine protease inhibitors
may be extremely abundant and diverse, combining multiple structurally unrelated protein families.
The exact function of these proteins remains unknown but it has been postulated that they inhibit
the frog’s endogenous peptidases that release functional skin peptides from their precursors, thereby
preventing the premature activation of toxins [2]. However, another plausible hypothesis is that a large
abundance of protease inhibitors in skin secretion may protect cosecreted bioactive peptides against
exogenous enzymatic degradation.
Second, we find a considerable diversity of transcripts encoding homologues of cytolytic
antimicrobial peptides and proteins (AMPs). Cytolytic peptides are a widespread and well-documented
component of amphibian skin secretions but typically constitute peptide families confined to a specific
taxon or clade, like magainins (in pipid frogs), bombinins (in bombinatorid frogs) and members of
the FSAP superfamily (in neobatrachian frogs) [1,2]. The primary role of these frog-specific peptides
as antimicrobial agents of the innate immune system has recently been challenged in favor of an
antipredatory function [1,15]. However, in both Phrynomantis species, AMP transcripts represent
ancient protein families that are evolutionary conserved among vertebrates and whose role in innate
immunity is undisputed. While beta-defensins, cathelicidins and lysozymes have been sporadically
found in amphibians before [41–43], bactericidal permeability-increasing proteins (BPI) represent
a new finding. Unlike other AMPs, they are large glycoproteins (typically 450-550 amino-acids)
whose cytotoxic activity against bacteria is thought to be mediated by their affinity for negatively
charged lipopolysaccharides [44]. It would be interesting to investigate whether the diversity of
ancient vertebrate AMPs is similar across all frog taxa or whether it reflects an evolutionary pattern
of functional replacement with frog-specific cytolytic peptides. At least in Phrynomantis, ancient
vertebrate AMP families seem to serve the antimicrobial function that is attributed to frog-specific
cytolytic peptides in other taxa.
Third, phrynomantins, like FSAP in other frog taxa, represent a major structural diversity indicative
of fast sequence diversification. Although only three of the nine predicted P. microps peptides were
confirmed by LC-MS, the high expression levels of their transcripts indicate that they represent an
important component of the Phrynomantis skin secretion. Discrepancies between transcriptome and
proteome data have been reported before (e.g., in snake venom studies) [45,46] and may be explained
by biological and/or analytical factors. Biological factors may include uncorrelated temporal variation
in transcription and peptide synthesis, posttranscriptional regulatory processes and rapid peptide
degradation upon secretion. Analytical factors may include false positives in transcript-based peptide
prediction, peptide concentrations below the LC-MS detection threshold, (in) stability of the charged
peptides, possible co-elution of molecules and adduct formation complicating the interpretation of
MS spectra.
Unlike most known FSAP, the majority of predicted phrynomantins is anionic. Although
negatively charged skin peptides have been described in frogs before [2,47], cytolytic skin peptides are
predominantly positively charged pore-forming peptides that are presumed to bind negatively charged
constituents of the outer surface of cell membranes [1,2]. Contrary to phrynomantins, anionic peptides
of the genera Bombina, Xenopus and Leptodactylus have been found to have cytolytic activity to some
degree [47–49]. In the case of those peptides, the pore-forming effect is likely attributed to their high
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hydrophobic moment and helicity, which facilitate cell membrane binding and insertion. The absence
or low degree of helicity in the majority of phrynomantins could explain their lack of cytolytic activity.
To test bioactivities other than cytotoxicity, we relied on the scarce published information on P.
microps skin secretion [20,24–26]. Based on our results, we cannot conclude that any of these peptides
functions as an inflammatory toxin or broad-spectrum insecticidal agent. However, since we only tested
for a general toxic effect on a commonly used insect model, it is still possible that these peptides could
have adverse effects on sympatric arthropods or even function as specific toxins against the Paltothyreus
tarsatus ants whose nests are inhabited by P. microps frogs [20]. Nonetheless, the observation that
injection of the frog’s full secretion shows an instant lethal effect on the wax moth larvae suggests that
this insect model is suitable for evaluating toxic components in Phrynomantis poison. Neither individual
phrynomantin peptide nor the mixture of five peptides produced any observable adverse effects on
the larvae, indicating that another, yet unidentified component of the skin secretion is responsible for
the observed insecticidal effect. Apart from peptides, many amphibians possess poisons based on
steroidal toxins (like bufadienolides), alkaloids or bioactive amines (like serotonin) [50,51]. Additional
chemical analysis should be conducted to verify whether such molecules also occur in Phrynomantis
skin secretions. However, the consistently high expression of phrynomantins in both species suggests
that they serve an important function for the frogs. Future studies that aim to characterise the biological
role of phrynomantins could perhaps start from known bioactivities of noncytolytic peptides belonging
to the FSAP superfamily, such as bradykinins, tachykinins or dermorphin.
One understudied effect that could increase a frog’s survival chance during a predator attack is a
foul or bitter taste. The capacity to perceive bitter molecules is generally regarded as a widespread
adaptation in animals to recognise and repel toxic food [52–54] and prey animals can take advantage of
taste perception in predators by secreting bitter-tasting molecules. When carefully tasting small volumes
of P. microps peptide solutions without ingestion, we noticed that two of them, phrynomantin-3Mc and
phrynomantin-4Ma, indeed have a bitter taste. Phenylseptin, an FSAP from the secretion of the hylid
tree frog Boana punctata, was previously found to elicit a bitter taste causing an adverse response in
mice [55]. The bitterness of Phenylseptin was attributed to a repeat sequence of three phenylalanine
residues. Together with other amino acid motifs (e.g.; Gly-Leu, Gly-Phe) Phe-repeats have been
shown to facilitate bitter taste receptor activation [55,56]. Interestingly, phrynomantin-4Ma contains a
Phe-Phe (FF) motif that could explain its bitter taste, while phrynomantin-M3a possesses a bitter taste
despite the absence of such motif. Whether these peptides can truly protect a frog from predation via
an adverse taste response could be explored via an integrative approach involving in vitro receptor
activation assays and in vivo behavioural trials.
Despite their structural uniqueness and unknown bioactivity, phrynomantins represent the
evolutionary counterpart of AMPs and neuropeptides found in other neobatrachian frogs. Our
phylogenetic analysis recovers phrynomantins as closely related to the peptides described from
the Kassina species [1,2], including mostly AMPs (e.g., kasseptins, galensin and senegalin) and the
histamine-releasing peptide kassinakinin S [57]. This result mirrors the prevalent hypothesis on
neobatrachian phylogeny [34–36]—the majority of molecular phylogenetic studies of frogs support
a sister-clade relationship between Microhylidae (including Phrynomantis) and Afrobatrachia, an
African clade including Hyperoliidae (and thus Kassina) along with Arthroleptidae, Brevicipitidae and
Hemisotidae [35,36]. In addition, the inferred FSAP tree supports monophyly of phrynomantins, as
well as of Kassina FSAP, ranid + dicroglossid FSAP and hyloid FSAP. This pattern of taxon-specific
FSAP clades suggests an early neobatrachian origin of the superfamily but a much later onset of its
expansion. Although a single FSAP gene appeared before the last common ancestor of hyloid and
ranoid frogs (as previously shown) [14], it only underwent major diversification after the divergence of
the major neobatrachian lineages, by multiple gene duplication events within each of these frog taxa.
In contrast to Ranidae and Hylidae, and despite a comparable ecological and taxonomic
diversity, microhylid frogs have remained largely understudied when it comes to their skin secretion.
Apart from P. microps [20], only three microhylid species have been the subject of published
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investigation—Dermatonotus muelleri (Gastrophryninae), Dyscophus guineti (Dyscophinae) and Kaloula
pulchra (Microhylinae). Peptides were not recovered in any of these species, suggesting the evolutionary
loss of peptide secretion and of the FSAP superfamily. The finding of FSAP members in Phrynomantis
(Phrynomerinae) implies that this peptide superfamily has been preserved in at least one microhylid
subfamily. Interestingly, although phylogenetic relationships among microhylid subfamilies remain
largely unresolved, most recent molecular studies agree on a basal divergence of Phrynomerinae from
all other microhylids [18,19,34–36,58,59]. The absence of FSAP across various microhylid taxa, along
with their presence in Phrynomantis, is consistent with a single evolutionary loss of this peptide system
in an early stage of the microhylid radiation, after the basal divergence of Phrynomerinae. Screening of
microhylid frogs representing additional subfamilies could further elucidate the evolutionary history
of this skin peptide repertoire.
Rather unexpectedly, our analyses did not recover any transcript that could encode either of the
two previously described P. microps peptides reported to be involved in ant repellence [20]. Similarly,
no trace of the peptides was found by subsequent peptidome analyses. Several factors could explain
why these peptides are absent from our data. First, their absence could be attributed to geographic
differences in peptide repertoires among different P. microps populations, since this species has a wide
distribution range across the savannah regions of West Africa [20,25,26]. Such variation has been
found across populations of North American and European ranid frogs [60,61] and may either involve
sequence differences (different populations producing different isoforms of a single peptide family)
or variation in peptide expression (peptides are produced in some populations but not in others). In
P. microps, such variation may be correlated to the extent to which different populations aestivate in
ant nests. Second, temporal differences in gene expression could explain why our captive animals
seemed to lack the two chemical camouflage peptides. In Pelophylax frogs, peptide synthesis was
found to be influenced by microbial factors, with animals kept under sterile conditions ceasing to
produce AMPs. Rehousing of animals with a normal microbial community restored peptide synthesis
in the skin [62,63], showing that environmental factors can impact the composition of amphibian
skin secretions. It is therefore possible that P. microps only synthesises these molecules when living
alongside P. tarsatus ants.
4. Materials and Methods
4.1. Ethics Statement
Experiments involving live animals were conducted in accordance with European guidelines
and Belgian legislation on animal housing and experimentation and were approved by the Ethical
Committee of Animal Experimentation of the Vrije Universiteit Brussel (Permit nos. EC15-AAA-2 and
EC16-334-1).
4.2. Animal Housing and Sample Collection
Adult Phrynomantis bifasciatus (n = 2) and Phrynomantis microps frogs (n = 3) were purchased from
terrarium shops. The P. bifasciatus frogs were immediately euthanized using a 10% lidocaine solution
(10 µL/g body weight) and freshly dissected dorsal skin tissue was stored in RNAlater (Sigma Aldrich).
After overnight cooling at 4 ◦C, the tissue samples were transferred to −20 ◦C for long-term storage.
Skin samples of two P. microps frogs were obtained in the same way but after sampling of their skin
secretion. The P. microps frogs were housed in an animalarium with a 12/12 h day-and-night cycle at
21–25 ◦C in glass terraria of 45 × 45 × 60cm (L × B × H). Skin secretion was sampled by placing each
frog separately in a Ziploc bag and manually massaging them to simulate the secretion. After five
minutes, secreted fluid on the frogs’ skin and the bags’ inner surface was collected in a microcentrifuge
tube using a spatula. For peptidome analyses, the secretion of the three animals was pooled and
diluted by adding five volumes of 1% (V/V) trifluoroacetic acid (TFA) and dissolved by brief vortexing.
The pooled samples were filtered twice through a 0.45 µm pore filter (Acrodisc®, Pall Laboratories Co.;
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Port Washington, NY, USA) and stored at −20 ◦C. For insecticidal assays (see below), fresh secretion
samples of the same three frogs were pooled and diluted with five volumes of ultrapure (milli-Q) water.
4.3. Transcriptome Analyses
Skin tissue (150 mg per individual frog) was homogenized using a GentleMacsTM dissociator
(Milteny Biotec; Bergisch Gladbach, Germany) and RNA was extracted using an RNeasy Universal
Plus Midi kit (Qiagen; Hilden, Germany). Purified RNA of individual frogs was pooled together
for RNA-seq analysis. A paired-end sequencing library was constructed using a TruSeq stranded
RNA-seq library preparation kit (Illumina Inc., San Diego, CA, USA) and the Illumina HiSeqTM 2500
sequencing system (outsourced to BaseClear BV, Leiden, The Netherlands). After quality control
(FASTQC v0.10.0 plus in-house QC protocols), results were further analysed using the Illumina Casava
pipeline (v.1.8.3) to generate FASTQ sequence files. Transcript sequences were reconstructed de novo
using a pipeline involving contig assembly by Trinity 2.5.1 [27], clustering of closely related contigs
using CD-Hit EST [28] and estimation of transcript expression levels (in transcripts per million; TPM)
using Kallisto 0.44.0 [64]. The resulting library was screened for peptide-encoding transcripts using
(1) blast homology searches against the NCBI protein database filtered for vertebrate sequences and
(2) blastx searches against an in-house built database of known amphibian skin peptides. Transcripts
that returned positive blast hits (e-values < 10−5) were scanned for the presence of N-terminal signal
peptides using SignalP 4.1 [65] and were visually checked for basic peptide cleavage sites (-KR-, -RR-
and -RXXR-) to predict the full sequence of functional peptides. Predicted peptides were submitted to
the online structure prediction tool PSIPRED v3.3 [31] to assess the likelihood of secondary structures.
To identify candidate transcripts encoding the two previously described P. microps peptides [20],
the assembled transcript libraries were screened using blastx searches against a database containing
the two peptides as well as all isoforms that differed in one amino acid (382 peptides in total). Since it
is possible that these searches will not give positive hits due to short sequence of the peptides, we
additionally used a text editor to screen a library of translated sequences using the two peptides as
search strings. This library was obtained by translating all open-reading frames > 150 bp in the two
Phrynomantis transcript libraries using the Trinity utility Transdecoder [27].
4.4. Peptidome Analyses
To confirm the actual secretion of predicted peptides in P. microps, 10 µL of diluted skin secretion
sample was injected into a Waters Breeze analytical HPLC system coupled to a Micromass Q-Tof
micro system. The HPLC is equipped with a Waters 2696 pump, Waters 2489 UV/visible detector (at a
wavelength of 215 nm) and a Grace Vydac C18 column (15 cm × 2.1 mm × 3 µm) with a flow rate of 0.3
mL/min. Electrospray data were acquired by electrospray positive ionization mode (ESI+) scanning
over the mass-to-charge ratio (m/z) scale from 100 to 3000 at a scan time of one second and a cone
voltage of 38 V. Data collection and analysis were done with Masslynx software (Waters Co.).
4.5. Peptide Synthesis
Five of the predicted peptides were de novo synthesized using solid-phase technology (outsourced
to Synpeptide, Shanghai, China) and delivered as HPLC-purified TFA salts (>95%). Peptide salts were
stored as 5.12 mM stock solutions in 0.01% (V/V) acetic acid/0.2% (m/V) BSA at 4 ◦C until further use.
4.6. Antimicrobial and Cytotoxicity Assays
Peptides were tested for antimicrobial activity against the gram-negative species Escherichia coli
(ATCC 25922) and the gram-positive species Staphylococcus aureus (ATCC 25923) and for cytotoxic
activity towards intestinal epithelial cells using the human cancerous colonic cells (Caco-2) monolayer
model. All assays were performed in triplicate. Antimicrobial activity against bacteria was measured
by assessing the lowest peptide concentration at which no growth was detected in a series of twofold
dilutions (minimum inhibitory concentration, MIC). Bacterial cultures (5 × 105 colony forming units
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per ml) were prepared in Müller-Hinton broth and transferred to serial dilutions of peptides ranging
from 512 µM down to 1 µM in 96-well polypropylene plates. After incubation at 37 ◦C for 18 h, growth
of the cultures was visually checked.
The cytotoxic activity of peptides against Caco-2 cells was measured by quantifying the fraction
of surviving cells after peptide treatment using a neutral red assay. Caco-2 cells were seeded at an
initial concentration of 5 × 105 cells/mL in Hank’s balanced salt solution medium with Mg2+ and Ca2+
(HBSS+) in polystyrene flat-bottom 96-well plates and incubated for 21 days (at 37 ◦C, 5% CO2 and
95% humidity) to grow morphologically differentiated monolayers of interconnected cells. Cytotoxic
activity of peptides was verified by exposing the resulting monolayers for 15 min to a range of peptide
concentrations between 512 and 0.5 µM. Five wells with cell medium only (HBSS+) and five wells
containing 1% Triton-X solution were used as negative and positive controls, respectively. After 15
min, peptide solutions were removed and 200 µL neutral red solution (33 µg/mL) was added to each
well. After two hours of incubation at 37 ◦C, the dye solution was removed and cells were rinsed three
times with 200 µL HBSS+ solution. Wells were then incubated with 200 µL glacial acetic acid solution
(glacial acetic acid: ethanol: water = 1:50:49) for 10 min in darkness. Finally, 150 µL medium from
each well was transferred to an optically clear ELISA well-plate, after which the optical density (OD)
was measured at 550 nm using a multiskan microplate photometer/ELISA reader (Thermo Scientific,
Waltham, MA, USA). The cytotoxic activity for each peptide concentration, expressed as a percentage,
was calculated as 100 × (ODobs − OD0)/(OD100 − OD0), where ODobs is the OD measured for the
peptide concentration, OD0 is the average OD for the negative controls (0% cytotoxicity) and OD100 is
the average OD after treatment with Triton-X (100% cytotoxicity).
4.7. Insecticidal Activity Experiments
Insecticidal activity was tested on larvae of the greater wax moth Galleria mellonella [66,67].
Sixth-instar larvae were obtained from a commercial source (Live Bait Shop, The Netherlands) and
kept at 15◦C to avoid cocoon formation. Only healthy larvae with a weight between 200 mg and 400
mg were used in the experiment. The experiment consisted of exposing randomly defined groups
of larvae (n = 8) to one of the following treatments—(1) injection of 20 µL 6× diluted P. microps skin
secretion (in mQ water; see 2.2), to assess whether the skin secretion as a whole has any insecticidal
activity; (2) for each peptide, injection of 20 µL 1mM solution (dissolved in 0.01% acetic acid/0.2% BSA),
to investigate the insecticidal activity of individual peptides; (3) injection of all peptides together (each
at 1 mM) to test for a possible synergistic effect among the peptides; (4) injection of 20 µL of the 0.01%
acetic acid/0.2% BSA solvent, to serve as a negative control and (5) no injection, to serve as background.
Injections involved insertion of a 30 G needle in the last left proleg. After injection, larvae were placed
on their backs in a 10 × 10 cm box to check for a reorientation response (turning of the body until the
ventral side faced the bottom). A grid paper with 5 × 5 mm squares placed on the bottom of the box
was used to measure crawling activity of the larvae at 10 min and 60 min after reorientation, quantified
as the number of squares through which the head moved during a one-minute interval. Individuals
were checked for dark discoloration of the skin (indicating the onset of dying) and responsiveness to
tactile stimuli (indicating sedation or onset of death) before each measurement of crawling activity.
We used generalized linear modelling as implemented in SPSS (version 24) to test for differences in
crawling activity (counts/min) among treatments (treatment as main effect), using a negative binomial
distribution and a Sidak post-hoc test. Differences in crawling activity were considered significant
at p < 0.05.
4.8. Inflammation Assays
Spleen and bone marrow (tibia and femur) cells were obtained by homogenizing the organs of three
CO2 euthanized eight-weeks-old female C57Bl/6 mice in 10 mL RPMI medium, passing the suspension
through a 40 mm pore filter (removing crude debris) and centrifugation (7 min, 398 g, 4 ◦C). The
pellet was treated with erythrocyte-lysis buffer to remove red blood cells from the mixture, following
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centrifugation (7 min, 398 g, 4 ◦C) and resuspending of the pellet in 2–5 mL RPMI medium plus 5% Fetal
Calf serum (FCS). Cells were counted to bring them at 2.5 × 106 cells/mL in RPMI-1640 medium with
10% FCS plus 1% nonessential amino acid mixture (Sigma-Aldrich), glutamate and streptomycin and
transferred to polystyrene cell culture well plates (180 µL per well). After adding 20 µL of 1mM peptide
solution (resulting in a 100 µM peptide concentration), cell cultures were incubated for two hours in a
humidified incubator (37 ◦C, 5% CO2). Negative control wells were created by adding 20 µL of 0.01%
acetic acid/0.2% BSA (solvent without peptide) and positive control wells were created by adding 20 µL
of 1 µg/mL E. coli lipopolysaccharide/endotoxin (LPS). After incubation, all cell cultures media were
collected from the wells and submitted to different enzyme-linked immunosorbent assays (ELISA),
measuring the amounts of released TNF-α (R&D systems, USA), NO (Nitric oxide; R&D systems,
USA), INF-γ (Pharmingen Inc. Taiwan) and IL-6 (Pharmigen Inc. Taiwan). All ELISA were performed
according to the suppliers’ manuals, with all optical densities (OD) measured at the recommended
wavelength using a multiskan microplate photometer/ELISA reader (Thermo Scientific, USA).
4.9. Phylogenetic Analyses
Spleen To reconstruct the evolutionary history of newly discovered peptide-encoding transcripts,
they were aligned with 102 FSAP transcript sequences retrieved from GenBank. These sequences
represent the majority of previously described FSAP peptide families across various neobatrachian
taxa. The alignment was created using the E-INS-I algorithm implemented in MAFFT 7.407 [68].
Phylogenetic relationships were estimated with MrBayes 3.2.6 [69] using a general time-reversible
model of DNA substitution with gamma correction for among-site rate heterogeneity and an estimated
proportion of invariable sites (GTR + G + I). Two runs of four Markov chain Monte Carlo chains each
were executed in parallel for 20 million generations, with a sampling interval of 1000 generations and a
burning of two million generations. Convergence of the parallel runs was confirmed by split frequency
standard deviations (<0.01) and potential scale reduction factors (approximating 1.0) for all model
parameters using Tracer 1.7 [70], by verifying if the runs had reached effective sampling sizes > 200 for
all model parameters.
5. Conclusions
The present study provides an overview of the repertoires of skin-secreted peptides and proteins
of Phrynomantis bifasciatus and P. microps, two poisonous species belonging to the poorly studied frog
family Microhylidae. Our results suggest a major structural diversity and high abundance of serine
protease inhibitors and of ancient vertebrate antimicrobial peptide and protein families. In addition, we
demonstrate that the frog skin active peptide (FSAP) superfamily, a widespread group of evolutionarily
related bioactive peptides has been evolutionarily preserved in at least one microhylid lineage. Their
deviant structural diversity and physicochemical properties compared to related peptides in other
frogs warrants their classification in a new peptide family (phrynomantins). Despite the current lack
of a known biological function, the discovery of phrynomantins encourages research on the skin
secretion of other microhylid frogs. In addition, our study could inspire the exploration of similarly
understudied frog neobatrachian families, like the comparably species-rich and ecologically diverse
Centrolenidae, Craugastoridae, Hemiphractidae and Arthroleptidae. Broadening the research to
encompass a wider range of frog families would not only further elucidate the origin and evolution of
the FSAP superfamily as a fascinating chemical defence adaptation but also reveal new peptides with
previously unknown physicochemical properties and bioactivities.
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